Oramed Pharmaceuticals Inc. Granted Patents in Japan and Canada for Its POD™ Technology for the Oral Delivery of Proteins
JERUSALEM, October 3, 2013 /PRNewswire via COMTEX/ -- Oramed Pharmaceuticals Inc. (nasdaqcm:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has received two additional patent approvals for its platform Protein Oral Delivery (POD(TM)) technology in Japan and Canada. Both granted patents are titled "Methods and Compositions for Oral Administrations of Proteins."
About POD(TM) Technology
Oramed's proprietary Protein Oral Delivery (POD(TM)) technology is based on over 30 years of research by top scientists at Jerusalem's Hadassah Medical Center. Addressing the obstacles to the oral administration of small protein (peptide) molecules, POD(TM) technology both protects and enhances protein delivery and absorption via the digestive system and into the bloodstream. In this way Oramed's POD(TM) technology can be used to develop oral alternatives for a number of today's injectable therapies.
For more information on Oramed's POD(TM) technology, please refer to the Company website: http://www.oramed.com
About Oramed Pharmaceuticals
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines currently delivered via injection. Established in 2006 and based on Oramed's platform POD(TM) technology, Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801) currently initiating Phase 2 clinical trials on patients with type 2 diabetes (T2DM) under an Investigational New Drug application with the U.S. Food and Drug Administration, and with its oral exenatide capsule (ORMD-0901; a GLP-1 analog), with trials on healthy volunteers (Phase 1b) and T2DM patients (Phase 2a) underway. Oramed is also moving forward with clinical trials of ORMD-0801 for the treatment of type 1 diabetes. The company's corporate and R&D headquarters are based in Jerusalem.
For more information, the content of which is not part of this press release, please visit http://www.oramed.com.
Help employers find you! Check out all the jobs and post your resume.